Article info
PDFHarm
Randomised controlled trial
Whether the use of unopposed oestrogen following a myocardial infarction is beneficial or harmful remains unclear, and in individual women the effects may vary according to the underlying risk profile
- Correspondence to : Professor Samuel Shapiro, Faculty of Health Sciences, School of Public Health and Family Medicine, Falmouth Building, University of Cape Town, Observatory, 7925, South Africa; samshap{at}mweb.co.za
Citation
Whether the use of unopposed oestrogen following a myocardial infarction is beneficial or harmful remains unclear, and in individual women the effects may vary according to the underlying risk profile
Publication history
- First published July 9, 2014.
Online issue publication
October 25, 2017
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions